Health Technology Integration Life Sciences Pharmaceuticals 
HIT Consultant
OCTOBER 25, 2022
Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.
HIT Consultant
JUNE 7, 2023
Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? We’re still pulling teeth – both literally and figuratively – to sustain an integrated, data-secured, patient-first way of managing healthcare data. But is that really all that true? questionable. And it’s 2023!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
AUGUST 22, 2022
That report spoke to the importance of connecting the disconnected health care landscape, including primary care, pharmacy, diagnostics, secondary care/hospitals, health technology providers, insurers, and information stewards, among other stakeholders in the fragmented health/care ecosystem.
HIT Consultant
MARCH 15, 2022
OptimizeRx , a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. Strategic Partnerships. Platform Launches.
Health Populi
DECEMBER 19, 2022
For over ten years, digital health technology has been a fast-growing area at the annual CES , the largest convention covering consumer electronics in the world. The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid.
Expert insights. Personalized for you.
98 
Let's personalize your content